• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

韩国成人疫苗接种史中的里程碑。

Milestones in history of adult vaccination in Korea.

作者信息

Oh Myoung-Don, Lee Jong-Koo

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Clin Exp Vaccine Res. 2012 Jul;1(1):9-17. doi: 10.7774/cevr.2012.1.1.9. Epub 2012 Jul 31.

DOI:10.7774/cevr.2012.1.1.9
PMID:23596574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3623517/
Abstract

Vaccination is one of the most effective and cost-benefit interventions that reduced the mortality. Major vaccine preventable diseases have decreased dramatically after the introduction of immunization program in Korea. In this article, we review milestones in history of immunization program, especially in adult vaccination.

摘要

接种疫苗是降低死亡率最有效且成本效益最高的干预措施之一。在韩国实施免疫规划后，主要的疫苗可预防疾病大幅减少。在本文中，我们回顾免疫规划历史上的里程碑事件，尤其是成人疫苗接种方面的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a98/3623517/5a304c7401cf/cevr-1-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a98/3623517/5a304c7401cf/cevr-1-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a98/3623517/5a304c7401cf/cevr-1-9-g001.jpg

相似文献

1
Milestones in history of adult vaccination in Korea.韩国成人疫苗接种史中的里程碑。
Clin Exp Vaccine Res. 2012 Jul;1(1):9-17. doi: 10.7774/cevr.2012.1.1.9. Epub 2012 Jul 31.
2
An immunization program for US-bound refugees: Development, challenges, and opportunities 2012-present.美国难民免疫接种计划：2012 年至今的发展、挑战与机遇。
Vaccine. 2021 Jan 3;39(1):68-77. doi: 10.1016/j.vaccine.2020.10.047. Epub 2020 Nov 18.
3
Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon.疫苗可预防疾病负担、疫苗接种覆盖率趋势以及扩大免疫规划实施中的当前挑战：喀麦隆的情况分析。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1939620. doi: 10.1080/21645515.2021.1939620. Epub 2021 Jul 1.
4
Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.通过整合现有的公共卫生基础设施，在国家免疫规划中成功引入一种未得到充分利用的老年肺炎球菌疫苗。
Vaccine. 2016 Mar 18;34(13):1623-1629. doi: 10.1016/j.vaccine.2016.01.043. Epub 2016 Feb 3.
5
The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.免疫规划对意大利 10 种疫苗可预防疾病的影响：1900-2015 年。
Vaccine. 2018 Mar 7;36(11):1435-1443. doi: 10.1016/j.vaccine.2018.01.065. Epub 2018 Feb 7.
6
Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.评估刚果民主共和国针对儿童的不同麻疹疫苗接种策略的成本效益。
Vaccine. 2017 Oct 27;35(45):6187-6194. doi: 10.1016/j.vaccine.2017.09.038. Epub 2017 Sep 28.
7
Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013.2013年埃及国家免疫规划中引入肺炎球菌结合疫苗（PCV-13）的成本效益分析
Vaccine. 2015 May 7;33 Suppl 1:A182-91. doi: 10.1016/j.vaccine.2014.12.044.
8
Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.韩国国家免疫计划轮状病毒疫苗接种的经济学评价。
Asia Pac J Public Health. 2013 Mar;25(2):145-58. doi: 10.1177/1010539511416806. Epub 2012 Jan 10.
9
Overview of the United States' Immunization Program.美国免疫计划概述。
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S443-S451. doi: 10.1093/infdis/jiab310.
10
Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea.韩国儿童7价肺炎球菌结合疫苗的经济学评估。
J Manag Care Pharm. 2010 Jan-Feb;16(1):32-45. doi: 10.18553/jmcp.2010.16.1.32.

引用本文的文献

1
Monkeypox: the resurgence of forgotten things.猴痘：被遗忘事物的再现。
Epidemiol Health. 2022;44:e2022082. doi: 10.4178/epih.e2022082. Epub 2022 Sep 26.
2
Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China.中国孕妇流感疫苗接种覆盖率增加的现状与挑战综述。
Hum Vaccin Immunother. 2020 Mar 3;16(3):602-611. doi: 10.1080/21645515.2019.1664230. Epub 2019 Oct 7.
3
Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea.

本文引用的文献

1
Adult Immunization Policy in Korea.韩国的成人免疫政策。
Infect Chemother. 2023 Sep;55(3):317-321. doi: 10.3947/ic.2023.0089.
2
2009-2010 novel influenza A (H1N1) vaccination coverage in the Republic of Korea.2009-2010 年新型甲型流感（H1N1）在韩国的疫苗接种覆盖率。
Am J Infect Control. 2012 Jun;40(5):481-3. doi: 10.1016/j.ajic.2011.05.015. Epub 2011 Aug 25.
3
Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine.
鉴于韩国汉坦病毒疫苗（Hantavax®）使用情况的变化，引入疫苗组学以开发个性化疫苗
J Prev Med Public Health. 2019 Sep;52(5):277-280. doi: 10.3961/jpmph.19.018. Epub 2019 Aug 7.
4
Investigation of a Mumps Outbreak in a Dental Clinic at a University Hospital.某大学医院牙科诊所腮腺炎疫情调查
Infect Chemother. 2019 Sep;51(3):256-262. doi: 10.3947/ic.2019.51.3.256.
5
Effectiveness of inactivated hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome.灭活汉坦病毒疫苗对肾综合征出血热疾病严重程度的有效性。
Kidney Res Clin Pract. 2018 Dec;37(4):366-372. doi: 10.23876/j.krcp.18.0044. Epub 2018 Dec 31.
6
Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.在韩国，18-60 岁成年人中使用裂解型四价流感疫苗的免疫原性和安全性。
Hum Vaccin Immunother. 2018 Mar 4;14(3):587-592. doi: 10.1080/21645515.2017.1381808. Epub 2017 Nov 17.
7
Recommended immunization schedule for adults in Korea, by the Korean Society of Infectious Diseases, 2012.韩国传染病学会2012年推荐的韩国成年人免疫接种计划。
Clin Exp Vaccine Res. 2014 Jan;3(1):110-2. doi: 10.7774/cevr.2014.3.1.110. Epub 2013 Dec 18.
8
Leptospirosis in the republic of Korea: historical perspectives, current status and future challenges.韩国的钩端螺旋体病：历史视角、现状与未来挑战
Infect Chemother. 2013 Jun;45(2):137-44. doi: 10.3947/ic.2013.45.2.137. Epub 2013 Jun 26.
2009年甲型H1N1流感裂解灭活疫苗在年轻人和老年人中的免疫原性及安全性：MF59佐剂疫苗与非佐剂疫苗的比较
Clin Vaccine Immunol. 2011 Aug;18(8):1358-64. doi: 10.1128/CVI.05111-11. Epub 2011 Jun 29.
4
Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial.6 个月至<18 岁健康儿童接种甲型 H1N1 流感病毒灭活裂解疫苗的安全性和免疫原性：一项前瞻性、开放性、多中心试验。
Vaccine. 2010 Aug 16;28(36):5857-63. doi: 10.1016/j.vaccine.2010.06.060. Epub 2010 Jun 30.
5
A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers.一项评估新型细胞培养痘苗疫苗 CJ-50300 在健康志愿者中的疗效和安全性的随机、双盲、对照临床试验。
Vaccine. 2010 Aug 16;28(36):5845-9. doi: 10.1016/j.vaccine.2010.06.063. Epub 2010 Jun 30.
6
Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.在未接种过牛痘和之前已接种过疫苗的人群中对天花疫苗的临床反应：单盲、随机、前瞻性试验中未稀释和稀释的兰西痘苗疫苗
J Infect Dis. 2005 Sep 15;192(6):1066-70. doi: 10.1086/432765. Epub 2005 Aug 11.
7
Protective effectiveness of hantavirus vaccine.汉坦病毒疫苗的保护效力
Emerg Infect Dis. 2004 Dec;10(12):2218-20. doi: 10.3201/eid1012.040684.
8
Review of an inactivated vaccine against hantaviruses.一种抗汉坦病毒灭活疫苗的综述。
Intervirology. 2002;45(4-6):328-33. doi: 10.1159/000067925.
9
Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea.对福尔马林灭活肾综合征出血热疫苗（汉坦病毒疫苗）的原发性体液免疫反应：韩国主动免疫的考量
Yonsei Med J. 2001 Jun;42(3):278-84. doi: 10.3349/ymj.2001.42.3.278.
10
Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax).人类对一种灭活汉坦病毒疫苗（Hantavax）的抗体反应。
Vaccine. 1999 Jun 4;17(20-21):2569-75. doi: 10.1016/s0264-410x(99)00057-2.